-
Mashup Score: 0
Tamoxifen reduced the risk of invasive ipsilateral breast recurrence in patients with good-risk ductal carcinoma in situ.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4Orca-T Leads to Retrospective OS Improvement in High-Risk Hematologic Malignancies After Allo-HCT - 8 day(s) ago
Orca-T was retrospectively associated with improved OS in patients with high-risk hematologic malignancies undergoing allogeneic stem cell transplant.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Orca-T Leads to Retrospective OS Improvement in High-Risk Hematologic Malignancies After Allo-HCT @UCLAHealthJCCC @ASH_hematology #ASH24 #oncology https://t.co/mqMbGc03xA
-
-
Mashup Score: 4Orca-T Leads to Retrospective OS Improvement in High-Risk Hematologic Malignancies After Allo-HCT - 9 day(s) ago
Orca-T was retrospectively associated with improved OS in patients with high-risk hematologic malignancies undergoing allogeneic stem cell transplant.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Orca-T Leads to Retrospective OS Improvement in High-Risk Hematologic Malignancies After Allo-HCT @UCLAHealthJCCC @ASH_hematology #ASH24 #oncology https://t.co/mqMbGc03xA
-
Tamoxifen reduced the risk of invasive ipsilateral breast recurrence in patients with good-risk ductal carcinoma in situ. @ASH_hematology #ASH24 #oncology https://t.co/3Is1hIwiOV https://t.co/nasYLRrrcn